HomeABEO • NASDAQ
add
Abeona Therapeutics Inc
Previous close
$6.48
Day range
$6.52 - $6.66
Year range
$3.93 - $7.32
Market cap
338.66M USD
Avg Volume
2.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 19.73M | 176.95% |
Net income | -12.03M | 61.91% |
Net profit margin | — | — |
Earnings per share | -0.24 | 54.08% |
EBITDA | -19.19M | -38.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 84.16M | 34.98% |
Total assets | 99.36M | 32.79% |
Total liabilities | 57.97M | -30.75% |
Total equity | 41.40M | — |
Shares outstanding | 51.16M | — |
Price to book | 7.62 | — |
Return on assets | -47.35% | — |
Return on capital | -74.47% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -12.03M | 61.91% |
Cash from operations | -18.40M | -26.58% |
Cash from investing | 4.21M | 153.90% |
Cash from financing | 6.77M | -73.40% |
Net change in cash | -7.42M | -340.55% |
Free cash flow | -14.99M | -43.63% |
About
Founded
1974
Headquarters
Website
Employees
136